个人研究简介：
教授，博导，泰山学者青年专家，省海外优青，山东大学杰出中青年学者、齐鲁青年学者。近年来，主要围绕生殖健康、慢性病及认知老化三者关系开展研究，以独立第一或通讯在中科院一区发表该领域文章多篇，包括 Lancet Public Health（2篇，2019&2023）、Circulation、EclinicalMedicine、PLOS Medicine、European Journal of Epidemiology（2篇）、American Journal of Obstetrics & Gynecology、Human Reproduction（2篇）、Stroke等。同时围绕热点问题开展健康的社会决定因素研究，成果发表在Am J Public Health、Infect Dis Poverty、J Travel Med等期刊。入选2021年ISI Web of Science高被引论文和热点论文1篇。成果被“美国心脏协会（American Heart Association, AHA）科学声明”、“欧洲心脏协会（European Society of Cardiology, ESC）共识声明”、“欧洲绝经期和更年期协会（EMAS）立场声明”、和“国际更年期协会白皮书”引用。研究成果两次获得保罗-达德利-怀特国际学者奖（Paul Dudley White International Scholar，美国心脏协会授予）、澳大利亚公共卫生协会高等研究学位卓越研究奖、和国家优秀自费留学生奖（国家留学基金委颁发）。BMC geriatrics、Scientific Reports、前沿系列Frontiers in Public Health、Frontiers in Medicine和Frontiers in Reproductive Health编委。
学术兼职：中华医学会临床流行病与循证医学分会方法学组委员，中国卫生信息与健康医疗大数据学会慢病防治专业委员会委员，山东省医学会临床流行病与循证医学分会副主任委员，山东预防医学会医疗机构公共卫生分会副主任委员。
承担的主要研究课题：
1. 国家自然基金面上项目（2023-2026），主持
2. 国家重点研发计划 重点专项（2023-2025），项目骨干
3. 泰山学者青年专家项目（2022-2025），主持
4. 山东省优秀青年基金（海外）项目（2022-2025），主持
5. 山东大学齐鲁青年学者计划项目（2020-2025），主持
6. 生命历程视角研究生殖健康与慢性疾病的国际合作研究 (InterLACE)，海外项目：澳大利亚健康和医学研究委员会(NHMRC)，2016.11-2020.01，230万，项目骨干；
7. 基础胰岛素治疗的观察登记性研究，中华医学会糖尿病学分会项目，2014.07-2016.09，500万以上，项目骨干；
8. 民航飞行人员用药安全性评价方法和指标体系研究，省部级纵向项目：首都卫生发展科研专项，2012.12-2015.12，13.7万，项目负责人（PI）
部分代表性论著：
Zhu D, Chung HF, Dobson A, et al. Age at natural menopause and risk of incident cardiovascular disease: a pooled analysis of individual patient data. The Lancet Public Health. 2019; 4(11): PE553-E564. PMID: 31588031
Fu C, Hao W, Shrestha N, Virani SS, Mishra SR, Zhu D*. Association of reproductive factors with dementia: A systematic review and dose-response meta-analyses of observational studies. EClinicalMedicine. 2021 Dec 14;43:101236. PMID: 34977513.
Zhu D*, Ozaki A, Virani SS. Disease-Specific Excess Mortality During the COVID-19 Pandemic: An Analysis of Weekly US Death Data for 2020. Am J Public Health. 2021 Aug;111(8):1518-1522. PMID: 34185569.
Ma Y, Mishra SR, Han XK, Zhu DS*. The relationship between time to a high COVID-19 response level and timing of peak daily incidence: an analysis of governments' Stringency Index from 148 countries. Infect Dis Poverty. 2021 Jul 5;10(1):96. PMID: 34225774.
Zhu D*, Mishra SR, Han X, Santo K. Social distancing in Latin America during the COVID-19 pandemic: an analysis using the Stringency Index and Google Community Mobility Reports. J Travel Med. 2020.
Zhu D, Chung HF, Pandeya N, et al. Relationships between intensity, duration, cumulative dose, and timing of smoking with age at menopause: A pooled analysis of individual data from 17 observational studies. PLoS Medicine. 2018;15(11):e1002704. PMID: 30481189.
Zhu D, Chung HF, Dobson AJ, et al. Type of menopause, age of menopause and variations in the risk of incident cardiovascular disease: pooled analysis of individual data from 10 international studies. Hum Reprod. 2020;35(8):1933-43. doi:10.1093/humrep/deaa124
Zhu D*, Chung HF, Dobson AJ, et al. Vasomotor menopausal symptoms and risk of cardiovascular disease: a pooled analysis of six prospective studies. Am J Obstet Gynecol. 2020. doi:10.1016/j.ajog.2020.06.039
Zhu D*, Chung HF, Pandeya N, et al. Premenopausal cardiovascular disease and age at natural menopause: a pooled analysis of over 170,000 women. European Journal of Epidemiology, 2019; 34(3):235-246. PMID: 30721378.
Zhu D, Chung HF, Pandeya N, et al. Body mass index and age at natural menopause: an international pooled analysis of 11 prospective studies. European Journal of Epidemiology. 2018; 33(8):699-710. PMID: 29460096
Zhu. D*, Mishra. SR, Virani. SS. A way to track governments' response and people's mobility changes in response to COVID-19 pandemic. J Glob Health. 2020(10):020345.
Zhu, D.*, Chung, H.F., Dobson, A, Pandeya, N and Mishra, G., 2019. P120: Women With Menopause After Age 45 And Take Hormone Therapy After Age 60 Increase The Risk Of Cardiovascular Disease. Circulation.
Zhu, D.*, Chung, H.F., Pandeya, N., Dobson, A. and Mishra, G., 2019. Abstract MP28: Early Menopause is Associated With Early-Onset Cardiovascular Disease Before Age of 60 Years. Circulation, 139(Suppl_1), pp.AMP28-AMP28.
